Skip to Content

Tesamorelin Dosage

Medically reviewed on March 5, 2018.

Applies to the following strengths: 1 mg; 2 mg

Usual Adult Dose for:

Additional dosage information:

Usual Adult Dose for Lipodystrophy

2 mg subcutaneously once a day

Comments:
-Long term cardiovascular safety and benefit have not been studied.
-Not indicated for weight loss (weight neutral effect).
-There are no data to support improved compliance with anti-retroviral therapies in HIV positive patients.

Use(s): Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:
-Disruption of the hypothalamic-pituitary axis due to hypophysectomy, hypopituitarism, pituitary tumor/surgery, head irradiation, or head trauma
-Active malignancy (newly diagnosed or recurrent)
-Hypersensitivity to tesamorelin and/or mannitol (an excipient)
-Pregnancy

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-Administer into abdominal skin subcutaneously, rotating sites.
-Do not inject into scar tissue, bruises, or the navel.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide